Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $3.23 down -1.22% from the previous closing price of $3.27. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 1.59 million shares were traded. RCKT stock price reached its highest trading level at $3.39 during the session, while it also had its lowest trading level at $3.2.
Ratios:
For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.30 and its Current Ratio is at 7.30. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On August 20, 2025, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $10.
BofA Securities Downgraded its Buy to Neutral on July 25, 2025, while the target price for the stock was maintained at $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’25 when Schwartz Jonathan David sold 2,545 shares for $2.98 per share. The transaction valued at 7,592 led to the insider holds 299,064 shares of the business.
Shah Gaurav sold 6,276 shares of RCKT for $18,721 on Nov 18 ’25. The CEO now owns 778,296 shares after completing the transaction at $2.98 per share. On Nov 18 ’25, another insider, Militello John, who serves as the insider of the company, sold 1,086 shares for $2.98 each. As a result, the insider received 3,240 and left with 65,920 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 349557792 and an Enterprise Value of 151844800.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.48, which has changed by -0.71712804 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $13.35, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is -6.26%, while the 200-Day Moving Average is calculated to be -24.61%.
Shares Statistics:
Over the past 3-months, RCKT traded about 2.46M shares per day on average, while over the past 10 days, RCKT traded about 2289310 shares per day. A total of 108.21M shares are outstanding, with a floating share count of 99.61M. Insiders hold about 7.95% of the company’s shares, while institutions hold 86.14% stake in the company. Shares short for RCKT as of 1764288000 were 11029132 with a Short Ratio of 4.48, compared to 1761868800 on 11034830. Therefore, it implies a Short% of Shares Outstanding of 11029132 and a Short% of Float of 19.790001.
Earnings Estimates
. The current market rating for Rocket Pharmaceuticals Inc (RCKT) reflects the collective analysis of 13.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.37 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.66 and -$2.19 for the fiscal current year, implying an average EPS of -$2.02. EPS for the following year is -$1.29, with 12.0 analysts recommending between $0.69 and -$1.83.
